Free Trial
Investment Research Tools for the A.I. EraStart My Trial

Haleon (HLN) Stock Forecast & Price Target

Haleon logo
GBX 330.40 +0.10 (+0.03%)
As of 03:23 AM Eastern
Compare

Haleon - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold
Based on 4 Analyst Ratings
Sell
1
Hold
1
Buy
2

Based on 4 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 4 analysts, 1 has given a sell rating, 1 has given a hold rating, and 2 have given a buy rating for HLN.

Consensus Price Target

GBX 436.67
According to the 4 analysts' twelve-month price targets for Haleon, the average price target is GBX 436.67. The highest price target for HLN is GBX 500, while the lowest price target for HLN is GBX 370. The average price target represents a forecasted upside of 32.16% from the current price of GBX 330.40.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLN Analyst Ratings Over Time

TypeCurrent Forecast
10/8/24 to 10/8/25		1 Month Ago
9/8/24 to 9/8/25		3 Months Ago
7/10/24 to 7/10/25		1 Year Ago
10/9/23 to 10/8/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetGBX 436.67GBX 435GBX 457GBX 367.50
Consensus RatingHoldHoldBuyModerate Buy

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Haleon Stock vs. The Competition

TypeHaleonMedical Companies
Consensus Rating Score
2.25
2.33
Consensus RatingHoldHold
News Sentiment Rating
Positive News

See Recent HLN News
Positive News
Export to Excel
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
9/10/2025The Goldman Sachs Group
3 of 5 stars		 Reiterated RatingNeutral ➝ BuyGBX 440+18.44%
8/8/2025Berenberg Bank
2 of 5 stars		 Lower TargetBuyGBX 503 ➝ GBX 500+41.08%
8/1/2025JPMorgan Chase & Co.
2 of 5 stars		 Reiterated RatingUnderweight
7/31/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Reiterated RatingSector performGBX 370+1.12%
4/18/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Initiated CoverageBuy
4/9/2024Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Lower TargetOverweightGBX 390 ➝ GBX 383+19.28%
10/11/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Boost TargetGBX 340 ➝ GBX 360+6.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:44 AM ET.


Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 3, 2025. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Haleon plc:

  • The stock has recently been given a "buy" rating by The Goldman Sachs Group, indicating positive sentiment from analysts.
  • Haleon plc has a diverse product portfolio that includes well-known brands like Advil and Centrum, which are built on trusted science and innovation.
  • The current stock price is around GBX 356.70, which may present a buying opportunity given the potential upside indicated by analysts.
  • The company reported a net margin of 9.66%, suggesting efficient management and profitability, which can be attractive to investors.
  • Haleon plc has a market capitalization of approximately £31.93 billion, indicating a strong presence in the consumer health industry.

Haleon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Haleon plc for these reasons:

  • JPMorgan Chase & Co. has issued an "underweight" rating, suggesting that the stock may not perform as well as others in the market.
  • The company's debt-to-equity ratio is relatively high at 53.36, which may indicate higher financial risk compared to peers.
  • Haleon plc's stock has experienced fluctuations, with a fifty-two week low of GBX 346.10, which could raise concerns about volatility.
  • Analysts have mixed ratings on the stock, with some recommending a "hold" or "sell," reflecting uncertainty in its future performance.
  • The price-to-earnings ratio is notably high at 2,135.93, which may suggest that the stock is overvalued compared to its earnings potential.

HLN Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Haleon is GBX 436.67, with a high forecast of GBX 500 and a low forecast of GBX 370.

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There is currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.

According to analysts, Haleon's stock has a predicted upside of 32.16% based on their 12-month stock forecasts.

Haleon has been rated by research analysts at Berenberg Bank, JPMorgan Chase & Co., Royal Bank Of Canada, and The Goldman Sachs Group in the past 90 days.

Analysts like Haleon less than other "medical" companies. The consensus rating score for Haleon is 2.25 while the average consensus rating score for "medical" companies is 2.33. Learn more on how HLN compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (LON:HLN) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners
Buy UBER immediately
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...
Chaikin Analytics | Sponsoredtc pixel
URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...
StockEarnings | Sponsoredtc pixel
$15 Fund: Turn Gold Boom into Real Income
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsoredtc pixel
Get my No. 1 gold stock now
Gold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...
Stansberry Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
U.S. Government Blocked NVIDIA’s Buyout… Here’s Why
The U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...
Behind the Markets | Sponsoredtc pixel
"I'm risking my reputation on this"
My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...
Crypto 101 Media | Sponsoredtc pixel